Adam Raymakers
@araymakers.bsky.social
Health economist & research fellow with the Program on Regulation, Therapeutics, & Law (PORTAL) at Harvard Medical School.
Interests: drug pricing/policy, health technology assessment, climate change.
Squamish, BC
www.linkedin.com/in/araymakers
Interests: drug pricing/policy, health technology assessment, climate change.
Squamish, BC
www.linkedin.com/in/araymakers
October 12, 2025 at 1:53 PM
Some more @cnn.com coverage of our study, led by @wbfeldman.bsky.social, on greenhouse gas emissions associated with inhaler use in the US.
October 9, 2025 at 12:47 AM
Some more @cnn.com coverage of our study, led by @wbfeldman.bsky.social, on greenhouse gas emissions associated with inhaler use in the US.
Really excited to share, and happy have been a part of, this new paper led by @wbfeldman.bsky.social out today in @jama.com!
We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US.
Read it here: jamanetwork.com/journals/jam...
We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US.
Read it here: jamanetwork.com/journals/jam...
October 6, 2025 at 8:37 PM
Really excited to share, and happy have been a part of, this new paper led by @wbfeldman.bsky.social out today in @jama.com!
We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US.
Read it here: jamanetwork.com/journals/jam...
We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US.
Read it here: jamanetwork.com/journals/jam...
July 28, 2025 at 4:14 PM
Great and engaging panel discussion about the future of the Inflation Reduction Act by @benro.me and Chris Cai (both from @portalresearch.org), @dusetzinas.bsky.social (Vanderbilt Health Policy), and Alyson Bancroft (@p4ad.bsky.social)!
#ARM25
#ARM25
June 9, 2025 at 11:02 PM
Great and engaging panel discussion about the future of the Inflation Reduction Act by @benro.me and Chris Cai (both from @portalresearch.org), @dusetzinas.bsky.social (Vanderbilt Health Policy), and Alyson Bancroft (@p4ad.bsky.social)!
#ARM25
#ARM25
Presenting some work on spending associated with drugs for ultra-rare diseases at the @academyhealth.bsky.social
Annual Research Meeting!
#arm25 @portalresearch.org
Annual Research Meeting!
#arm25 @portalresearch.org
June 9, 2025 at 2:15 PM
Presenting some work on spending associated with drugs for ultra-rare diseases at the @academyhealth.bsky.social
Annual Research Meeting!
#arm25 @portalresearch.org
Annual Research Meeting!
#arm25 @portalresearch.org
Chris Cai from @portalresearch.org presenting on private equity acquisitions of health care delivery organizations at the @academyhealth.bsky.social Annual Research Meeting.
#arm25
#arm25
June 8, 2025 at 9:14 PM
Chris Cai from @portalresearch.org presenting on private equity acquisitions of health care delivery organizations at the @academyhealth.bsky.social Annual Research Meeting.
#arm25
#arm25
Opening plenary underway with @aaronecarroll.bsky.social at the @academyhealth.bsky.social Annual Research Meeting.
#arm25
#arm25
June 8, 2025 at 4:24 PM
Opening plenary underway with @aaronecarroll.bsky.social at the @academyhealth.bsky.social Annual Research Meeting.
#arm25
#arm25
Opening plenary underway with @aaronecarroll.bsky.social at the @academyhealth.bsky.social Annual Research Meeting.
#arm25
#arm25
June 8, 2025 at 4:23 PM
Opening plenary underway with @aaronecarroll.bsky.social at the @academyhealth.bsky.social Annual Research Meeting.
#arm25
#arm25
On my way to the Academy Health (@academyhealth.bsky.social) Annual Research Meeting in Minneapolis with @jerryavorn.bsky.social in my ear!
#arm2025 @portalresearch.org
#arm2025 @portalresearch.org
June 7, 2025 at 2:40 PM
On my way to the Academy Health (@academyhealth.bsky.social) Annual Research Meeting in Minneapolis with @jerryavorn.bsky.social in my ear!
#arm2025 @portalresearch.org
#arm2025 @portalresearch.org
Looking forward to attending my first ever Academy Health Annual Research Meeting with fellow @portalresearch.org members @benro.me and Chris Cai!
I'll be presenting some work on spending associated with drugs for ultra-rare diseases on Sunday.
See you there!
#arm2025 @academyhealth.bsky.social
I'll be presenting some work on spending associated with drugs for ultra-rare diseases on Sunday.
See you there!
#arm2025 @academyhealth.bsky.social
June 6, 2025 at 10:59 PM
Looking forward to attending my first ever Academy Health Annual Research Meeting with fellow @portalresearch.org members @benro.me and Chris Cai!
I'll be presenting some work on spending associated with drugs for ultra-rare diseases on Sunday.
See you there!
#arm2025 @academyhealth.bsky.social
I'll be presenting some work on spending associated with drugs for ultra-rare diseases on Sunday.
See you there!
#arm2025 @academyhealth.bsky.social
Great talk today by Dr Beate Sander at the annual Vancouver Health Economics Methodology Meeting on economic evidence as a component of public health decision making, with lots of discussion about the societal perspective!
#healtheconomics #hta
#healtheconomics #hta
June 6, 2025 at 7:21 PM
Great talk today by Dr Beate Sander at the annual Vancouver Health Economics Methodology Meeting on economic evidence as a component of public health decision making, with lots of discussion about the societal perspective!
#healtheconomics #hta
#healtheconomics #hta
Nice night out there.
May 29, 2025 at 3:07 AM
Nice night out there.
Happy to have been able to help out with new research led by Ian Liu, with co-authors @asarpatwari.bsky.social and @akesselheim.bsky.social (@portalresearch.org).
We looked at trials, labelling changes, and revenues associated with the Best Pharmaceuticals for Children Act.
We looked at trials, labelling changes, and revenues associated with the Best Pharmaceuticals for Children Act.
May 27, 2025 at 8:39 PM
Happy to have been able to help out with new research led by Ian Liu, with co-authors @asarpatwari.bsky.social and @akesselheim.bsky.social (@portalresearch.org).
We looked at trials, labelling changes, and revenues associated with the Best Pharmaceuticals for Children Act.
We looked at trials, labelling changes, and revenues associated with the Best Pharmaceuticals for Children Act.
May 13, 2025 at 12:14 PM
Excited to get this brand new book by Jerry Avorn from @portalresearch.org in the mail today! Can't wait to give it a read!
@harvardmed.bsky.social
@harvardmed.bsky.social
April 23, 2025 at 5:22 PM
Excited to get this brand new book by Jerry Avorn from @portalresearch.org in the mail today! Can't wait to give it a read!
@harvardmed.bsky.social
@harvardmed.bsky.social
Happening now!
Dr Aaron Kesselheim (@akesselheim.bsky.social) providing testimony to the House Ways and Means Committee on "Lowering Costs for Patients: The Health of the Biosimilar Market."
waysandmeans.house.gov/event/health...
cc: @portalresearch.org
Dr Aaron Kesselheim (@akesselheim.bsky.social) providing testimony to the House Ways and Means Committee on "Lowering Costs for Patients: The Health of the Biosimilar Market."
waysandmeans.house.gov/event/health...
cc: @portalresearch.org
April 8, 2025 at 2:31 PM
Happening now!
Dr Aaron Kesselheim (@akesselheim.bsky.social) providing testimony to the House Ways and Means Committee on "Lowering Costs for Patients: The Health of the Biosimilar Market."
waysandmeans.house.gov/event/health...
cc: @portalresearch.org
Dr Aaron Kesselheim (@akesselheim.bsky.social) providing testimony to the House Ways and Means Committee on "Lowering Costs for Patients: The Health of the Biosimilar Market."
waysandmeans.house.gov/event/health...
cc: @portalresearch.org
March 6, 2025 at 5:04 PM
Our new paper just out in Health Affairs on the use of an administrative pathway (inter partes review) to challenge patents on brand name biologic products and the impact on revenue.
Co-authors: Victor van de Wiele, @akesselheim.bsky.social, and @seansst5.bsky.social
Link: t.co/YR4qbl3uGM
Co-authors: Victor van de Wiele, @akesselheim.bsky.social, and @seansst5.bsky.social
Link: t.co/YR4qbl3uGM
March 4, 2025 at 8:07 PM
Our new paper just out in Health Affairs on the use of an administrative pathway (inter partes review) to challenge patents on brand name biologic products and the impact on revenue.
Co-authors: Victor van de Wiele, @akesselheim.bsky.social, and @seansst5.bsky.social
Link: t.co/YR4qbl3uGM
Co-authors: Victor van de Wiele, @akesselheim.bsky.social, and @seansst5.bsky.social
Link: t.co/YR4qbl3uGM
Well, an earthquake wasn't on today's bingo card but here we are.
February 21, 2025 at 9:31 PM
Well, an earthquake wasn't on today's bingo card but here we are.
🚨 Just out today (online)! 🚨
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
January 31, 2025 at 8:11 PM
🚨 Just out today (online)! 🚨
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
Had an interesting discussion about cost-minimization analysis in the context of HTA yesterday which reminded me of writing this article a few years back! (with co-authors from @lshtm.bsky.social and @uniofgalway.bsky.social).
www.sciencedirect.com/science/arti...
#healtheconomics
www.sciencedirect.com/science/arti...
#healtheconomics
January 29, 2025 at 12:48 PM
Had an interesting discussion about cost-minimization analysis in the context of HTA yesterday which reminded me of writing this article a few years back! (with co-authors from @lshtm.bsky.social and @uniofgalway.bsky.social).
www.sciencedirect.com/science/arti...
#healtheconomics
www.sciencedirect.com/science/arti...
#healtheconomics
Franke made a mid ride mod (i.e., clawed a hole) in her new trailer. Much better now.
January 20, 2025 at 6:15 PM
Franke made a mid ride mod (i.e., clawed a hole) in her new trailer. Much better now.
January 8, 2025 at 4:43 PM